Clinical Trial Update: A Clinical Study of KRN321 in Adult Subjects With Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial of KRN321 in adults with myelodysplastic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• KRN321

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: MDS | Phase 2 | Status: COMPLETED